Reposted by Lars Henning
A succinct piece about the flurry of activities that continue to promote MCEDs despite the negative Grail-Galleri trial. "This environment doesn’t lend itself to unbiased decision making." (i.e. panels of experts with serious financial conflicts of interest).
www.bmj.com/content/395/...
bmj.com
Galleri: Trial results show why the NHS must not follow the US FDA in approving the multicancer test
After failing to meet the primary endpoint and controversy around lobbying and competing interests, the NHS must take its next steps cautiously, writes Margaret McCartney
On 22 September, the New En...
